VCAM1 and Miyoshi myopathy: Besides the mechanism of action describe above, MPT0G413/bortezomib combination significantly down-regulated the expression of vascular cell adhesion molecule-1 (VCAM-1) and VLA-4, leading to a reduction of MM cell adhesion to BMSCs.